Zepbound (tirzepatide) is a glucagon-like peptide-1 (GLP-1) agonist drug that can help people lose weight. It comes as a weekly injection and is only available with a prescription. While it’s possible ...
INDIANAPOLIS, Feb. 25, 2025 /PRNewswire/ -- Today Eli Lilly and Company (NYSE: LLY) announced the launch of 7.5 mg and 10 mg Zepbound (tirzepatide) single-dose vials, available for $499 with the new ...
Zealthy announced today the launch of its enhanced virtual weight-loss care platform, designed to simplify access to provider-guided obesity treatment through integrated telehealth services, insurance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results